Alektiar K M, Zelefsky M J, Brennan M F
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1273-9. doi: 10.1016/s0360-3016(00)00587-3.
We have previously shown that adjuvant brachytherapy (BRT) improves local control in soft tissue sarcoma (STS) of the extremity and superficial trunk. A detailed assessment of the morbidity of this approach has not been examined. The purpose of this study was to evaluate the toxicity associated with adjuvant BRT in terms of wound complications, bone fracture, and peripheral nerve damage.
Between July 1982 and June 1992, 164 adult patients with STS of the extremity or superficial trunk were randomized intraoperatively to receive or not to receive BRT after complete resection. BRT was delivered with (192)Ir to a total dose of 42-45 Gy. The BRT and no-BRT arms were balanced with regard to age, sex, presentation (primary vs. recurrent), site, grade, size, and depth. Morbidity was assessed in terms of significant wound complication, bone fracture, and peripheral nerve damage (grade > or = 3). The significant wound complications were defined as those wound problems requiring operative revision for coverage or threatened limb loss, persistent seroma requiring repeated aspirations and/or drainage, wound separation > 2 cm, hematoma > 25 ml, and/or purulent wound discharge. The median follow-up was 100 months.
The significant wound complication rate was 24% in the BRT group and 14% in the no-BRT group, (p = 0.13). The rate of wound reoperation, however, was significantly higher in the BRT arm (10% vs. 0%; p = 0. 006). Examination of other covariables that may have contributed to wound reoperation revealed the width of the excised skin (WES) to be a significant factor [1% (WES < or = 4 cm) vs. 10% (WES > 4 cm), p = 0. 02]. Bone fracture only occurred in patients receiving BRT (n = 3, 4%), although this was not statistically significant (p = 0.2). The rate of peripheral nerve damage, however, was similar in both arms (7% vs. 7%).
The overall morbidity associated with adjuvant BRT was not significantly higher than that with surgery alone. However, BRT and WES > 4 cm were associated with significantly higher wound reoperation rate. This has significant implications for strategies designed to maximize wound coverage in patients who receive BRT.
我们之前已经表明,辅助近距离放射治疗(BRT)可改善四肢及躯干浅表软组织肉瘤(STS)的局部控制。尚未对这种治疗方法的发病率进行详细评估。本研究的目的是从伤口并发症、骨折和周围神经损伤方面评估辅助BRT的毒性。
1982年7月至1992年6月期间,164例四肢或躯干浅表STS成年患者在术中随机分组,在完全切除后接受或不接受BRT。采用铱-192进行BRT,总剂量为42 - 45 Gy。BRT组和非BRT组在年龄、性别、表现形式(原发 vs 复发)、部位、分级、大小和深度方面保持平衡。根据严重伤口并发症、骨折和周围神经损伤(3级及以上)评估发病率。严重伤口并发症定义为那些需要手术修复以覆盖创面或有肢体丧失风险、持续性血清肿需要反复抽吸和/或引流、伤口裂开>2 cm、血肿>25 ml和/或脓性伤口分泌物的伤口问题。中位随访时间为100个月。
BRT组严重伤口并发症发生率为24%,非BRT组为14%(p = 0.13)。然而,BRT组伤口再次手术率显著更高(10% vs. 0%;p = 0.006)。对其他可能导致伤口再次手术的协变量进行检查发现,切除皮肤宽度(WES)是一个重要因素[1%(WES≤4 cm)vs. 10%(WES>4 cm),p = 0.02]。骨折仅发生在接受BRT的患者中(n = 3,4%),尽管这在统计学上无显著意义(p = 0.2)。然而,两组周围神经损伤发生率相似(7% vs. 7%)。
辅助BRT相关的总体发病率并不显著高于单纯手术。然而,BRT和WES>4 cm与显著更高的伤口再次手术率相关。这对于旨在最大化接受BRT患者伤口覆盖的策略具有重要意义。